Anti-psychotics drugs Flashcards
MOA 1st generation anti-psychotics
D2 receptor antagonists
ADRs of 1st generation anti-psychotics
- motor disturbances - fix with antimuscarinics
- increase prolactin release
- inhibit insulin release
- hypothermia
- suppresses vomiting centre
- cross-react with anti-muscarinics, antihistaminic, antiadrenergics: dry mouth, blurred vision, constipation, urinary retention, sedation, orthostatic hypotension, tachycardia, hypersensitivity and allergic reactions
clinical considerations 1st generation anti-psychotics
- good for positive symptoms, not for negative
- therapeutic effect in weeks, ADRs immediate
MOA 2nd generation clozapine
may have D4 selectivity
ADRs clozapine
absence seizures
sedation
neutropenia
why clozapine is better than 1st generation
reduced tardive dyskinesia
MOA 2nd generation risperidone
serotonin, D2 antagonist
ADR 2nd generation risperidone
weight gain
why risperidone over 1st generation
lower incidence of extrapyramidal effects and galactorrhea
can be administered parenterally
olanzapine over 1st generation
- well tolerated, lower incidence of galactorrhoea
ADRs olanzapine
weight gain, constipation, drowsiness
MOA aripiprazole
partial D2 agonist, agonist at some 5-HT, antagonist at others
ADRs aripiprazole
weight gain, drowsiness
why aripiprazole over 1st generation
well tolerated, comparable efficacy to haloperidol